Safety profile of various 5HT3 receptor antagonists used for PONV prophylaxis

Authors
Category Primary study
JournalJK Science
Year 2016
This article has no abstract
Epistemonikos ID: a6e595f904b069457f7b3c2b4a740b3821daeb68
First added on: Apr 29, 2026